California · 82104

Alpha-1-Antitrypsin (protein) Blood Test, Phenotype in California

California Medicare Avg
$13.91
2% below national avg
National Medicare Avg
$14.13
All states combined
Billed Charge (CA)
$144.78
What providers submit
Est. Commercial (CA)
$33.38
National avg: $31.64
Est. Cash / Self-Pay (CA)
$50.24
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.1K
Services in CA
17
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in California

Provider Medicare Services
Unilab Corporation $14.17 327
Laboratory Corporation Of America $14.17 256
Quest Diagnostics Nichols Institute $14.17 206
Unilab Corporation $14.17 199
Regents Of The University Of $9.80 65
Pacific Point Laboratories, Inc. $13.93 20

California Pricing in Context

In California, CPT code 82104 (Alpha-1-Antitrypsin (protein) Blood Test, Phenotype) carries an average Medicare payment of $13.91 — 2% below the national benchmark of $14.13. 17 providers across the state submitted claims for this procedure in 2023, performing 1.1K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in California is $144.78, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Blood Test procedures, the estimated commercial insurance price in California lands near $33.38, with self-pay cash prices typically around $50.24. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Alpha-1-Antitrypsin (protein) Blood Test, Phenotype cost in California?

The average Medicare payment for Alpha-1-Antitrypsin (protein) Blood Test, Phenotype in California is $13.91, which is 2% below the national average of $14.13. Providers in CA typically bill $144.78 for this procedure.

What does Alpha-1-Antitrypsin (protein) Blood Test, Phenotype cost with insurance in California?

With commercial insurance in California, Alpha-1-Antitrypsin (protein) Blood Test, Phenotype costs an estimated $33.38. Without insurance, the estimated cash price is $50.24. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Alpha-1-Antitrypsin (protein) Blood Test, Phenotype in California?

17 providers in California billed Medicare for Alpha-1-Antitrypsin (protein) Blood Test, Phenotype in 2023, performing 1.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Alpha-1-Antitrypsin (protein) Blood Test, Phenotype cheaper in California than the national average?

Yes — Alpha-1-Antitrypsin (protein) Blood Test, Phenotype costs 2% below the national average in California. The state average Medicare payment is $13.91 compared to $14.13 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial